Published in Hepatobiliary Pancreat Dis Int on August 01, 2010
Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol (2012) 2.23
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology (2008) 3.26
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol (2007) 2.11
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol (2005) 1.45
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol (2011) 1.44
Increased number and function of endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells (SECs) in cirrhosis through paracrine factors. J Hepatol (2012) 1.42
Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol (2003) 1.36
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 1.33
Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases. J Gastroenterol Hepatol (2004) 1.32
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol (2008) 1.27
Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol (2006) 1.20
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol (2010) 1.17
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet (2002) 1.11
Endoscopic management of postoperative bile leaks. Hepatobiliary Pancreat Dis Int (2006) 1.10
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol (2013) 1.08
Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease. J Gastroenterol Hepatol (2007) 1.08
Endoscopic management of acute cholangitis in elderly patients. World J Gastroenterol (2006) 1.02
Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol (2004) 1.01
Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol (2006) 0.98
Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol (2005) 0.94
Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther (2002) 0.94
Transient elastographic evaluation in adult subjects without overt liver disease: influence of alanine aminotransferase levels. J Gastroenterol Hepatol (2011) 0.91
Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol (2008) 0.91
Management of acute hepatitis B and reactivation of hepatitis B. Liver Int (2013) 0.89
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int (2012) 0.88
Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J Med Virol (2003) 0.87
Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol (2002) 0.86
Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience. J Gastroenterol Hepatol (2007) 0.86
Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am J Gastroenterol (2002) 0.85
CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. World J Gastroenterol (2006) 0.85
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int (2014) 0.85
Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells. FEBS J (2015) 0.84
Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene (2013) 0.83
Histological spectrum of chronic hepatitis in precore mutants and wild-type hepatitis B virus infection. Trop Doct (2004) 0.83
Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial. Liver Int (2013) 0.82
Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. J Gastroenterol Hepatol (2011) 0.82
Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol (2012) 0.82
Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int (2008) 0.82
Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol (2009) 0.81
Eosinophilic abscesses: a new facet of hepatic visceral larva migrans. Abdom Imaging (2013) 0.81
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India. Med Microbiol Immunol (2006) 0.81
Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol (2008) 0.81
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Cell Immunol (2004) 0.80
Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3. J Med Virol (2014) 0.80
Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India. Indian J Pathol Microbiol (2010) 0.79
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients. Gastroenterology (2009) 0.79
Liver regeneration during acute-on-chronic liver failure using growth factors: in vivo or ex vivo indulgence of bone marrow? Gastroenterology (2013) 0.79
Histological profile of liver disease in patients with dual hepatitis B and C virus infection. Indian J Pathol Microbiol (2003) 0.78
Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature. Blood Coagul Fibrinolysis (2013) 0.78
Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatol Int (2014) 0.78
Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients. J Gastroenterol Hepatol (2002) 0.78
A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein. Hepatobiliary Pancreat Dis Int (2004) 0.77
Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma. J Vasc Interv Radiol (2013) 0.77
Antiviral therapy in advanced chronic liver disease due to hepatitis C virus infection: pilot study. J Gastroenterol Hepatol (2005) 0.77
Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. Diabetes Metab Syndr (2012) 0.75
Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease. Gastroenterology (2009) 0.75
Anticoagulant thepary for portal vein thrombosis in liver: is it worth a buy? Gastroenterology (2013) 0.75
Steatohepatitic variant hepatocellular carcinoma: a case report of new histological variant. Trop Gastroenterol (2014) 0.75
Endoscopically diagnosed fistula between hepatic artery and first part of duodenum as a cause of massive upper gastrointestinal hemorrhage. Trop Gastroenterol (2012) 0.75
Seroprevalence of Blood Borne Pathogens among Health Care Workers and Their Hepatitis B Vaccination Status in Tertiary Care Hospitals in India. Glob J Health Sci (2016) 0.75
Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children. Vaccine (2002) 0.75
[Similarities and differences in definition and clinical diagnosis of acute-on-chronic liver failure: East vs. West]. Zhonghua Gan Zang Bing Za Zhi (2014) 0.75
Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection. Expert Rev Gastroenterol Hepatol (2008) 0.75
Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin. Eur J Gastroenterol Hepatol (2015) 0.75
Identification and full-length molecular characterization of rare hepatitis C virus genotype 5a from India. Arch Virol (2014) 0.75